Novel Approach to Early Detection of Doxorubicin Cardiotoxicity by Gadolinium-Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental Model
Author(s) -
James C. Lightfoot,
Ralph B. D’Agostino,
Craig A. Hamilton,
Jennifer H. Jordan,
Frank M. Torti,
Nancy D. Kock,
James E. Jordan,
Susan Workman,
W. Gregory Hundley
Publication year - 2010
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.109.918540
Subject(s) - medicine , ejection fraction , magnetic resonance imaging , cardiotoxicity , saline , gadolinium , doxorubicin , cardiology , nuclear medicine , heart failure , toxicity , chemotherapy , radiology , materials science , metallurgy
We sought to determine whether cardiovascular magnetic resonance measures of gadolinium (Gd) signal intensity (SI) within the left ventricular myocardium are associated with future changes in left ventricular ejection fraction (LVEF) after receipt of doxorubicin (DOX).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom